Ulcer Monitoring in Diabetes Mellitus (Telesaar)
Primary Purpose
Diabetes Mellitus, Foot Ulcers
Status
Unknown status
Phase
Phase 2
Locations
Denmark
Study Type
Interventional
Intervention
telemedicine consultations
Sponsored by
About this trial
This is an interventional treatment trial for Diabetes Mellitus focused on measuring diabetic foot ulcer, ulcer monitoring, telemedicine consultations, cross-sectoral collaboration
Eligibility Criteria
Inclusion Criteria:
- Having diabetic foot ulcer
- Referred for out-patient clinic treatment by general practitioner
- Referred for out-patient clinic treatment by a surgical department
- Living in Region of Southern Denmark
Exclusion Criteria:
- Psychiatric disorder
- Dementia
- Chronic alcohol abuse which can affect compliance
- Other disorder then diabetes mellitus that have caused foot ulcer (rheumatoid arthritis or arthritis urica)
- Serious kidney disease which requires dialysis
- Previous foot ulcer - which was part of the study
- Expected healing within 2-4 weeks where only one control (final) is expected
Sites / Locations
- South-west HospitalRecruiting
- Lillebaelt HospitalRecruiting
- Odense University HospitalRecruiting
- Hospital South JutlandRecruiting
- Svendborg HospitalRecruiting
- Hospital LillebaeltRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Control
Diabetes ulcer monitoring
Arm Description
Control group. Regular treatment.
Receives a telemedicine intervention: Diabetes ulcer monitoring.
Outcomes
Primary Outcome Measures
Admissions to hospital
The number of admissions, incl, beddays, to hospital relating to ulcer treatment for each randomised patient during the treatment period.
Surgical procedures
The number of surgical procedures (incl. amputations) performed at hospital in realtion to the ulcer during the treatment period.
Secondary Outcome Measures
Ulcer healing
The time from inclusion and start of treatment until ulcer is healed and treatment is stopped.
Full Information
NCT ID
NCT01608425
First Posted
May 24, 2012
Last Updated
June 4, 2013
Sponsor
Johnny Froekjaer
Collaborators
Region of Southern Denmark, European Commission
1. Study Identification
Unique Protocol Identification Number
NCT01608425
Brief Title
Ulcer Monitoring in Diabetes Mellitus
Acronym
Telesaar
Official Title
Impact Assessment by Introducing Telemedicine Consultations for Treatment of Diabetic Patients With Foot Ulcers in Region of Southern Denmark - Randomized Prospective Study
Study Type
Interventional
2. Study Status
Record Verification Date
June 2013
Overall Recruitment Status
Unknown status
Study Start Date
April 2011 (undefined)
Primary Completion Date
June 2013 (Anticipated)
Study Completion Date
November 2013 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Johnny Froekjaer
Collaborators
Region of Southern Denmark, European Commission
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Telemedicine technology enables a direct and online text- and image communication in the treatment system from patient to the ulcer specialist. The technology is expected to have patient-related, economic and therapeutic benefits. The study is a substudy of a larger project entitled "Renewing Health", where also the economic and management aspects are highlighted. However, only few randomized prospective studies are conducted in this field. The purpose of the study is in a randomized prospective study, to assess the impact of the introduction of the telemedicine technology as consultation form between ulcer-nurses in the primary sector and the wound clinics at the hospitals in the region. It is assessed whether the technology can be adopted without incurring the patient a risk. The study aims to perform an impact analysis of the introduction of new technologies for telemedicine wound monitoring in the treatment of diabetic foot ulcers through different studies.
Detailed Description
Through randomized and prospective studies the project will show whether a telemedicine approach to wound care can be used as an alternative to traditional attendance at a wound clinic and document whether this consultation form provides a greater patient-satisfaction and cost savings. The project will document that telemedicine is equivalent to conventional outpatient attendance from a therapeutic aspect in terms of number of hospitalizations, number of extra controls, acute interventions and wound healing.
The project is also investigating the extent of time spent on the personnel side using telemedicine consultations compared with conventional outpatient appearances.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Foot Ulcers
Keywords
diabetic foot ulcer, ulcer monitoring, telemedicine consultations, cross-sectoral collaboration
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
400 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Control
Arm Type
No Intervention
Arm Description
Control group. Regular treatment.
Arm Title
Diabetes ulcer monitoring
Arm Type
Experimental
Arm Description
Receives a telemedicine intervention: Diabetes ulcer monitoring.
Intervention Type
Procedure
Intervention Name(s)
telemedicine consultations
Other Intervention Name(s)
pleje.net
Intervention Description
Replacing 2 out of 3 patient visits to out-patient clinic at hospital with treatment at home from visiting nurse and telemedicine consultations with the specialist doctor.
Primary Outcome Measure Information:
Title
Admissions to hospital
Description
The number of admissions, incl, beddays, to hospital relating to ulcer treatment for each randomised patient during the treatment period.
Time Frame
from time of inclusion until treatment completed, assessed up to 52 weeks
Title
Surgical procedures
Description
The number of surgical procedures (incl. amputations) performed at hospital in realtion to the ulcer during the treatment period.
Time Frame
from time of inclusion until completed treatment, assessed up to 52 weeks
Secondary Outcome Measure Information:
Title
Ulcer healing
Description
The time from inclusion and start of treatment until ulcer is healed and treatment is stopped.
Time Frame
Progress is measured at minimum every 4 weeks during treatment period, assessed up to 52 weeks
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Having diabetic foot ulcer
Referred for out-patient clinic treatment by general practitioner
Referred for out-patient clinic treatment by a surgical department
Living in Region of Southern Denmark
Exclusion Criteria:
Psychiatric disorder
Dementia
Chronic alcohol abuse which can affect compliance
Other disorder then diabetes mellitus that have caused foot ulcer (rheumatoid arthritis or arthritis urica)
Serious kidney disease which requires dialysis
Previous foot ulcer - which was part of the study
Expected healing within 2-4 weeks where only one control (final) is expected
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Benjamin S. Rasmussen, MD
Phone
004560774050
Email
benjamin.schnack.rasmussen@ouh.regionsyddanmark.dk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Benjamin S. Rasmussen, MD
Organizational Affiliation
Odense University Hospital
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Johnny Froekjaer, MD
Organizational Affiliation
Odense University Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Knud B. Yderstraede, MD
Organizational Affiliation
Odense University Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
South-west Hospital
City
Esbjerg
State/Province
Region of Southern Denmark
ZIP/Postal Code
6700
Country
Denmark
Individual Site Status
Recruiting
Facility Name
Lillebaelt Hospital
City
Kolding
State/Province
Region of Southern Denmark
ZIP/Postal Code
6000
Country
Denmark
Individual Site Status
Recruiting
Facility Name
Odense University Hospital
City
Odense
State/Province
Region of Southern Denmark
ZIP/Postal Code
5000
Country
Denmark
Individual Site Status
Recruiting
Facility Name
Hospital South Jutland
City
Soenderborg
State/Province
Region of Southern Denmark
ZIP/Postal Code
6400
Country
Denmark
Individual Site Status
Recruiting
Facility Name
Svendborg Hospital
City
Svendborg
State/Province
Region of Southern Denmark
ZIP/Postal Code
5700
Country
Denmark
Individual Site Status
Recruiting
Facility Name
Hospital Lillebaelt
City
Vejle
State/Province
Region of Southern Denmark
ZIP/Postal Code
7100
Country
Denmark
Individual Site Status
Recruiting
12. IPD Sharing Statement
Citations:
PubMed Identifier
27638453
Citation
Fasterholdt I, Gerstrom M, Rasmussen BSB, Yderstraede KB, Kidholm K, Pedersen KM. Cost-effectiveness of telemonitoring of diabetic foot ulcer patients. Health Informatics J. 2018 Sep;24(3):245-258. doi: 10.1177/1460458216663026. Epub 2016 Sep 16.
Results Reference
derived
PubMed Identifier
26116717
Citation
Rasmussen BS, Froekjaer J, Bjerregaard MR, Lauritsen J, Hangaard J, Henriksen CW, Halekoh U, Yderstraede KB. A Randomized Controlled Trial Comparing Telemedical and Standard Outpatient Monitoring of Diabetic Foot Ulcers. Diabetes Care. 2015 Sep;38(9):1723-9. doi: 10.2337/dc15-0332. Epub 2015 Jun 26.
Results Reference
derived
Links:
URL
http://www.renewinghealth.eu/cluster-3/region-of-southern-denmark
Description
More information about the clinical study as part of a EU funded project
Learn more about this trial
Ulcer Monitoring in Diabetes Mellitus
We'll reach out to this number within 24 hrs